Clinical Trial Update: A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, efficacy, and tolerability of AZD8233 in participants with hyperlipidaemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidaemia

Drugs mentioned

• AZD8233

Snippet

Sponsor: AstraZeneca | Conditions: Hyperlipidaemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-15